lobal Fingolimod Market Expected to Witness Significant Growth Driven by Rising Prevalence of Multiple Sclerosis https://dataintelo.com/report/global-fingolimod-market The Fingolimod Market is witnessing strong growth, propelled by the rising global burden of multiple sclerosis (MS) and the increasing preference for oral disease-modifying therapies. Fingolimod, an oral sphingosine-1-phosphate receptor modulator, has gained prominence due to its efficacy in reducing relapse rates and delaying disability progression in MS patients.